Publications:

Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects.

Frontiers In Oncology

Peixoto, Ana A; Pinto, Pedro P; Guerra, Joana J; Pinheiro, Manuela M; Santos, Catarina C; Pinto, Carla C; Santos, Rui R; Escudeiro, Carla C; Bartosch, Carla C; Canário, Rita R; Barbosa, Ana A; Gouveia, Alfredo A; Petiz, Almerinda A; Abreu, Miguel Henriques MH; Sousa, Susana S; Pereira, Deolinda D; Silva, João J; Teixeira, Manuel R MR

Publication Date: 2020

Variant appearance in text: BRCA2: 19G>C

PubMed Link: 32850417

Variant Present in the following documents:

• Main text
• fonc-10-01318.pdf

View BVdb publication page

Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML.

Npj Breast Cancer

Hart, Steven N SN; Polley, Eric C EC; Shimelis, Hermella H; Yadav, Siddhartha S; Couch, Fergus J FJ

Publication Date: 2020

Variant appearance in text: BRCA2: 19G>C; Glu7Gln

PubMed Link: 32377563

Variant Present in the following documents:

• 41523_2020_159_MOESM3_ESM.xlsx, sheet 1

View BVdb publication page